Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.5 million individuals worldwide. With its portfolio of innovative dialysis products and therapies it has defined the highest standards for the treatment of patients with kidney failure and through its network of 3,250dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for over 270,000 patients around the globe.
Since its inception in 2000, Fresenius Medical Care Malaysia has grown to be the market leader in hemodialysis products and a significant provider of peritoneal dialysis products. It also provides care to about 1,000 patients in its network of 18 dialysis clinics. It has expanded its manufacturing footprint in Malaysia, initially through a plant manufacturing Reverse Osmosis Water Systems and recently in a plant manufacturing dialysis solutions to cater to the Malaysian and potentially the South East Asian markets.
Malaysia is an attractive destination for these and future investments because of its central location in Asia, its developed infrastructure, stable political situation, educated work force and supportive government policies. The pro-active support of various government agencies, such as MIDA, PEMANDU, BioTech Corp, Invest KL and its outstanding staff has efficiently facilitated the investment efforts of FMC in Malaysia.